| Pharmaceutical Information |
| Drug Name |
Moexipril hydrochloride |
| Drug ID |
BADD_D01485 |
| Description |
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. |
| Indications and Usage |
For the treatment of hypertension. |
| Marketing Status |
approved |
| ATC Code |
C09AA13 |
| DrugBank ID |
DB00691
|
| KEGG ID |
D00623
|
| MeSH ID |
C058302
|
| PubChem ID |
54889
|
| TTD Drug ID |
D00HDU
|
| NDC Product Code |
68462-208; 17404-0018; 0093-0017; 0093-5150; 66039-838; 68462-209 |
| UNII |
Q1UMG3UH45
|
| Synonyms |
moexipril | 2-((1-ethoxycarbony)-3-phenylpropylamino-1-oxopropyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | Fempress | moexipril hydrochloride | Univasc | Moex | Perdix | RS 10085 | RS-10085 |
|
| Chemical Information |
| Molecular Formula |
C27H35ClN2O7 |
| CAS Registry Number |
82586-52-5 |
| SMILES |
CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
